| OHDSI Home | Forums | Wiki | Github |
Hi everyone!
My name is Karla and I work at the Department of Science and Technology of the Brazilian Ministry of Health in the Clinical Research field. I’m very interested in how to collect and organize data to improve public health in my country. I’m also interested in learning about real-world data and real-world evidence.
Hi, My name is Kafi. I am a recent graduate of Health Economics Outcomes Research. Prior to going back to school. I worked as a pharmacist managing an independent pharmacy which was sold last year. I came across OHDSI from a HEOR meetup. I am looking to work In health care quality and also contribute in a meaningful way to this forum.
I like to read and watch movies in my free time.
Hi, I am transitioning into HEOR and looking for hands-on/ field/learning opportunities for graduate students in HEOR.
Thank you
Kafi
Hi everyone,
my name is Theresa Burkard, I am a PostDoc in observational research (my main research areas are metabolic and musculoskeletal disease). I am currently based in Zurich, Switzerland (ETH Zurich). I participated in the legendary Oxford OHDSI studyathon 2018 which lead to two papers (one accepted, one under review) and attended the OHDSI European Symposium in Rotterdam this year. So looking forward to more of that 
For the moment, I would like to participate in OHDSI projects to later on lead a project within the OHDSI community myself
See you soon!
Best wishes,
Theresa
Hi OHDSI Community,
I am Gerardo Machnicki, working as Director, Real World Evidence, Janssen Latin America. I have nineteen years experience in the pharmaceutical industry in roles involving health economics, outcomes research and analytics and my background is in health economics and epidemiology/public health.
I have been a supporter of OHDSI approach and tools since learning about it in 2015, and being fortunate to work with some leaders in this community, both at Janssen and outside it. I am happy to join the forums.
My general interests are about the analytic and patient level prediction tools provided by OHDSI and how these keep growing to implement better methods for observational research in epidemiology and health economics.
My other interest is about OHDSI growth in Latin America.
Among my OHDSI related activities: participanted in the 2018 Oxford RWE Summer School, facilitated the introduction of OHDSI concepts as a lead instructor in the first RWE short course at the ISPOR Latin American 2019 meeting, maintained several explorations and trainings with potential OHDSI participants in Latin America, engaging leaders such as @Patrick_Ryan, @krfeeney , @Daniel_Prieto and @jposada.
I look forward to more fruitful interactions involving the OHDSI community!
@Tereza_Abrahao @gabrielbvieira @ktauil @gmachnic - welcome friends!! We are delighted to have more collaborators from Latin America. There is a spot on the forum where we are trying to coordinate regional efforts. Make sure to fill out this Doodle poll: Nuevo grupo de trabajo: Latino OHDSI
It says Espanol… but really it’s intended to be a community spot for people doing conversions / OHDSI outreach in Latin America as well OR your mother tongue is Spanish or Portuguese (and you want to talk to people about OHDSI in your mother tongue :-D). So if you are “en portugues”… you are welcome too! @gmachnic and @jposada are kindly helping pull together the whole region so there could be local activities in 2020. 
Hi everyone- I’m Jenny Lane, a Trauma and Orthopaedic surgeon taking time out of training to do a PhD in Biomedical Data Science at the University of Oxford. I’m really excited about the disruptive and dynamic principles of the OHDSI community and would love to work within it. My main interest is in surgery and musculoskeletal conditions, and would also love to be part of the women in OHDSI group.
I’m very interested in investigating the association between aromatase inhibitor use for breast cancer with musculoskeletal conditions, and am currently working up a proposal to present to you. But first, I’ve been watching the forum and am aiming to join the conference calls today!
Hi everyone- I´m Esteban, a Colombian Data scientist, i’m new in the health industry but always i have felt curiosity about it . I just start a big project relate with health data for now our first obstacle is stucturraion of data for them
Greetings all, my name is Jim Frankfort. I trained and practiced as a physician for years but transitioned into informatics full time > 10 years ago. I’ve worked in the industry on creating platforms to measure quality and cost of healthcare. Recently I’ve been working on a FDA project containing a distributed surveillance network where my focus is on measuring and reporting data quality of the individual data partners and aggregate network as well. Looking forward to collaborating on data quality!
Hi My name is Edwin Duque from Medellín, Colombia. I am system engineering and a master of science in engineering (Human computer interaction). I am also a PhD Student working in objective assessment of the motor upper limb for spinal cord injury patients through analyzing position and rotation data.
Recently, I received a training in data science by CorrelationOne company and participate in a local competition creating an app that takes a medical image to see if it automatically detect bulge, protrusion or herniation in the lumbar spinal cord assigning priority to those patients that are more likely to have a stenosis.
I love to create things and help others, so I am determined to think, design and build innovative tech solutions that solve toughest problems in healthcare as well as to influence others to do the same. I would like to help creating tools but also writing papers.
Hello everyone, I am Conor Zhang, a thoracic surgeon at Peking Union Medical College Hospital, Beijing, China. I’m interested in survival after surgical resection in patients with lung cancer. I am new in the observational data research. It is my honor to be a member of OHDSI community.
Hello Everyone, My name is Ufuoma Olakpe but feel free to call me Ufi. I am a Project Manager/Business Analyst with Health Data Compass at the University of Colorado, Denver.
I am fairly new to the world of CDM and OMOP but have experience as a Business Intelligence developer building reports out of EPICs Caboodle Datawarehouse. I am very interested in Terminology mapping and Data Quality Maintenance in OMOP and I want to connect with any other people who have CDMd their EPIC Caboodle data! Please give me a shout out so we can connect! I appreciate any knowledge that I can get from the community and I am very happy to join such a fun community doing all this cool stuff!
HI all:
My name is Roy Mathew and I am nephrologist and researcher at the Columbia Veterans Affairs Health Care System in Columbia SC. I am very new to the OHDSI community as I was recently introduced by a colleague. We have just started to utilized VA Data that has been translated to OMOP format. I am very excited at the possibilities that this will bring in conducting observational research in the VA data. My immediate research interest revolves around cardiovascular health of patients with chronic kidney disease. I have previously utilized VA Corporate Data Warehouse (CDW) data for observational research.
I am very excited about the broader applicability of the CDM in terms of health care data portability and ultimately better transactional feedback for providers. I look forward to learning from the community and hopefully one day contribute in some meaningful manner.
In terms of myself - I am originally from NY and still consider NY my home. I am just buried in sports with my son when I am not at work (but I am also a bit of a junky as well - I love watching almost any sport - except for golf and baseball - too slow for my taste).
Looking forward to this. Great to e-meet so many talented individuals.
Roy
Hi Roy and welcome! Wondering if you or any of your colleagues might have interest in looking at cardiovascular health of patients with prostate cancer. Hormonal blockade treatments applied broadly among older men and men with metastatic disease, have been implicated in cardiovascular decline, and newer stronger hormonal treatments may be even more problematic. I am thinking that a lot of what you are doing might be ported to this application.
HI Ruth:
Thanks for the response. That would be a very interesting question - there has been some concern about testosterone replacement and CVD, but i have not heard about CV risk from androgen deprivation therapy. That would be an interesting question to ask and actually one that would be very easy to ask in a CDM.
The VA obviously would have a robust dataset for this as it is primarily older males and prostate cancer is a big issue. Androgen deprivation, in addition, is commonly used.
Roy
Hi everyone, I’m Manuel Salinas from Colombia, actually i’m working in health economics, actuary in health and Data Science, i want explore more tools and research approaches for bring more solutions in health.
Thanks
Hello, @mansalo92 OHDSI needs more experts on health economics. Thank you for joining.
We’ve been working on the package which can calculate DALY based on CDM data, of which name is Argos If you’re interested in this, please let me know
Cheers,
Chan
Hello, I just joined the OHDSI forums. My name is Mark and I will be working on a medical data project with Northwestern University. We are looking into using the OMOP data model in this so I look forward to collaborating and learning about the model and OHDSI. Nice to meet you all!
Hello!
I’m Nicole Washington, Director of Research at Helix (https://helix.com). I’ve been lurking on the OHDSI community calls for a couple months and intend to become more involved this year, as we grow our Population Health Genomics initiatives. I’m very interested in what I can bring to the Vocabulary working group, as I have >10 years experience developing and analyzing data annotated with ontologies. In addition, I have a strong interest in properly integrating and analyzing genomic data in the CDM.
I’ve previously worked with other large consortia and community-based efforts to design and implement standards to bring together genomics and health on a variety of axes (GA4GH, ENCODE, NCBO, OBO Foundry, UDN, Monarch). I look forward to working with the OHDSI community to facilitate the integration of seemingly messy healthcare data across health systems and domains with the lofty goal to improve healthcare for the masses.
Nicole